- Home
- SNTG vs APTO Comparison
SNTG vs APTO Comparison
Compare SNTG & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- APTO
- Stock Information
- Founded
- SNTG 2009
- APTO 1986
- Country
- SNTG China
- APTO Canada
- Employees
- SNTG N/A
- APTO N/A
- Industry
- SNTG Finance: Consumer Services
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNTG Finance
- APTO Health Care
- Exchange
- SNTG Nasdaq
- APTO Nasdaq
- Market Cap
- SNTG 6.1M
- APTO 6.7M
- IPO Year
- SNTG 2021
- APTO N/A
- Fundamental
- Price
- SNTG $2.25
- APTO $0.36
- Analyst Decision
- SNTG
- APTO Strong Buy
- Analyst Count
- SNTG 0
- APTO 4
- Target Price
- SNTG N/A
- APTO $9.00
- AVG Volume (30 Days)
- SNTG 19.9K
- APTO 66.5K
- Earning Date
- SNTG 10-29-2024
- APTO 11-07-2024
- Dividend Yield
- SNTG N/A
- APTO N/A
- EPS Growth
- SNTG N/A
- APTO N/A
- EPS
- SNTG N/A
- APTO N/A
- Revenue
- SNTG $146,554.00
- APTO N/A
- Revenue This Year
- SNTG N/A
- APTO N/A
- Revenue Next Year
- SNTG N/A
- APTO N/A
- P/E Ratio
- SNTG N/A
- APTO N/A
- Revenue Growth
- SNTG N/A
- APTO N/A
- 52 Week Low
- SNTG $1.47
- APTO $0.33
- 52 Week High
- SNTG $8.45
- APTO $3.32
- Technical
- Relative Strength Index (RSI)
- SNTG 53.72
- APTO 38.81
- Support Level
- SNTG $2.07
- APTO $0.35
- Resistance Level
- SNTG $2.27
- APTO $0.42
- Average True Range (ATR)
- SNTG 0.18
- APTO 0.02
- MACD
- SNTG -0.01
- APTO 0.00
- Stochastic Oscillator
- SNTG 29.22
- APTO 25.00
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.